CD40LG and metabolic dysfunction-associated steatotic liver disease: Earlier findings from others and us indicated that IgM antibodies recognising MDA epitopes reduce hepatic inflammation during metabolic dysfunction‐associated steatotic liver disease (MASLD) [20, 21, 22].